Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms

N Engl J Med. 1995 Feb 23;332(8):512-21. doi: 10.1056/NEJM199502233320807.

Authors

G N Levine¹, J F Keaney Jr, J A Vita

Affiliation

¹ Evans Memorial Department of Medicine, Boston University School of Medicine, MA.

PMID: 7830734
DOI: 10.1056/NEJM199502233320807

No abstract available

Publication types

Comment
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Review

MeSH terms

Anticholesteremic Agents / therapeutic use
Arteriosclerosis / etiology
Cardiovascular Diseases / etiology*
Cardiovascular Diseases / mortality
Clinical Trials as Topic
Endothelium, Vascular / physiopathology
Humans
Hypercholesterolemia / complications
Hypercholesterolemia / drug therapy*
Morbidity
Nitric Oxide / physiology

Substances

Anticholesteremic Agents
Nitric Oxide